QUEST DIAGNOSTICS INC·4

Mar 6, 4:43 PM ET

Deppe Michael J 4

Research Summary

AI-generated summary

Updated

Quest Diagnostics (DGX) SVP Michael J. Deppe Receives Stock Award

What Happened Michael J. Deppe, SVP, Corporate Controller & CAO of Quest Diagnostics (DGX), received 1,473 shares as a performance stock award on 2026-03-04 (value $301,759 at $204.86/share). At the same time 750 shares were surrendered back to the company to cover tax withholding obligations (disposition value $153,645). After withholding, Deppe kept a net 723 shares (net value ≈ $148,114).

Key Details

  • Transaction dates: 2026-03-04 (reported on Form 4 filed 2026-03-06).
  • Award: 1,473 shares @ $204.86 = $301,759 (code A = award/grant).
  • Tax withholding: 750 shares disposed @ $204.86 = $153,645 (code F = shares surrendered to issuer for tax withholding).
  • Net shares retained: 723 shares (1,473 − 750) with net value ≈ $148,114.
  • Footnotes: F1 — stock issued in settlement of a performance stock award under Rule 16b-3(d); F2 — disposition solely to cover tax withholding.
  • Timeliness: Filing was submitted within the Form 4 reporting window (timely).

Context This filing reflects settlement of a performance-based equity award, not an open-market purchase or sale. The disposition of shares was a routine cashless withholding to meet tax obligations and is common when awards vest; it should not be interpreted as a voluntary sale indicating sentiment.